🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07208942
Recruiting Observational

Diagnosis Value of Interoceptive EEG Indicators by Rectal Stimulation in DoC

NCT07208942 · tracked via the Priya Life Science China tracker
Sponsor
YiLin Zhao
Phase
Observational
Started
2024-12-01
Last updated
2025-10-06

Condition(s) studied

Disorders of Consciousness

Investigational drug(s) / intervention(s)

Rectal Stimulation

Rectal Stimulation: The stimulation balloon was lubricated with paraffin oil and inserted until the distal end of the balloon was 10 cm from the anal verge, so as to eliminate the influence of different stimulation sites on the subjects. At the start of stimulation, the dilatable balloon was rapidly inflated to 60/80 mL, with a stimulation duration of 150 milliseconds. Concurrently with stimulation, the onset time of stimulation was marked on the electroencephalogram (EEG), and the time window for cortical potentials evoked by rapid rectal balloon distension stimulation was recorded. During the experiment, 35 stimulations were administered to the subjects; however, the first and last stimulations were excluded due to setup issues with the precision inflation-deflation control device for the intestinal balloon. Each stimulation was delivered as a 150-millisecond inflation pulse, providing 35 identical rectal stimulations. The inter-stimulus interval was randomly set to 12 ± 4 seconds, and EEG signals were

Study summary

Study on the Significance and Value of Interoception-Related Indicators in the Classification of Patients with Disorders of Consciousness (DoC) via Rectal Stimulation

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with non-acute Disorders of Consciousness (DoC) (disease course ≥ 28 days). * Aged 18 years or older. * No symptoms of fever, infection, or other similar conditions within 15 days. * No use of sedatives within 15 days. * No use of any drugs that may alter gastrointestinal motility within 7 days prior to testing. * Family members of participating patients have provided consent and signed the informed consent form. Exclusion Criteria: * Patients with functional impairments caused by developmental psychiatric disorders or neurological diseases. * Patients with untreated epilepsy. * Untreated cerebral edema. * Patients with unstable vital signs. * A history of intestinal diseases. * A history of abdominal surgery other than simple appendectomy or simple cholecystectomy. * Organic diseases such as spinal cord injury, traumatic brain injury, and thyroid dysfunction.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
The Second People's Hospital of Hefei Hefei Anhui Recruiting
Hangzhou Normal University Hangzhou Zhejiang Enrolling By Invitation

More YiLin Zhao trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07208942 on ClinicalTrials.gov ↗ ← All trials in China